Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 24;16(1):493.
doi: 10.1186/s13023-021-02105-8.

Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective

Eugen Mengel  1 , Marc C Patterson  2 , Michael Chladek  3 , Christina Guldberg  4 , Christine Í Dali  4 , Tara Symonds  5 , Lucy Lloyd-Price  5 , Toni Mathieson  6 , Joslyn Crowe  7 , Claire Burbridge  8
Affiliations

Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective

Eugen Mengel et al. Orphanet J Rare Dis. .

Abstract

Background: Niemann-Pick disease type C (NPC) is a debilitating condition that impacts patients' and caregivers' quality of life (QOL) and reduces the patient's life expectancy. Since there is little qualitative research from the perspective of patients and family caregivers, this study explored the impact of NPC on patients' and caregivers' daily lives to understand the burden of disease.

Results: A survey of caregivers for patients with NPC and adult patients with NPC (n = 49; patient age: 13 months-65 years) assessed NPC severity, importance of NPC symptoms, and how symptoms impacted patients' and caregivers' activities of daily living (ADLs) and health-related QOL (HRQOL). Follow-up interviews with a subset of survey participants (n = 28) explored the ranking of NPC symptom importance and impact on ADLs and HRQOL. Findings indicated that the most important manifestations of NPC were ambulation, swallowing, speech, fine motor skills, and cognition, which were those that had the most significant impact on ADLs and HRQOL. A wide range of ADLs were affected by NPC, mainly eating/drinking and the ability to perform daily tasks, including self-care, communicating, participating in school or work, and moving indoors as well as outside the home. Along with these impacts, there was an increased risk of experiencing dangerous or life-threatening situations leading to loss of patient independence and additional caregiver burden, often requiring changes in lifestyle such as giving up work. All aspects of patients' and caregivers' HRQOL were affected. Participants reported feelings of social isolation, loss of enjoyment in activities (patients), and feelings of sadness or worry (caregivers).

Conclusions: Ambulation, swallowing, speech, fine motor skills, and cognition are important manifestations of NPC. ADLs and HRQOL were impaired in the majority of patients as well as their caregivers. The findings were independent of current age, age of onset of symptoms, and level of NPC disease-related disability; however, the impact increased at higher levels of disease disability. Knowing the impact of NPC on patients and caregivers is important for understanding the lived experience of NPC and for identifying potential areas of support.

Keywords: Illness burden; Impacts; NPC; Niemann pick Type-C; Qualitative.

PubMed Disclaimer

Conflict of interest statement

CG and CD are employees of Orphazyme A/S. TS, MP, MC, CB, LLP, EM, TM, and JC declare no competing interests.

Figures

Fig. 1
Fig. 1
Impact of NPC on patients’ ADLs
Fig. 2
Fig. 2
Impact of NPC on patients’ HRQOL
Fig. 3
Fig. 3
Impact of NPC on caregivers’ ADLs
Fig. 4
Fig. 4
Impact of NPC on caregivers’ HRQOL
See this image and copyright information in PMC

References

    1. Geberhiwot T, Moro A, Dardis A, et al. Consensus clinical management guidelines for Niemann-Pick Disease Type C. Orphanet J Rare Dis. 2018;13(1):50. doi: 10.1186/s13023-018-0785-7. - DOI - PMC - PubMed
    1. Hammond N, Munkacsi A, Sturley S. The complexity of a monogenic neurodegenerative disease: more than two decades of therapeutic driven research into Niemann-Pick type C disease. Biochim Biophy Acta Mol Cell Biol Lipids. 2019;1864:1109–1123. doi: 10.1016/j.bbalip.2019.04.002. - DOI - PubMed
    1. Vanier M. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5(16). 10.1186/1750-1172-1185-1116. - PMC - PubMed
    1. Naureckiene S, Sleat D, Lackland H, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–2301. doi: 10.1126/science.290.5500.2298. - DOI - PubMed
    1. Lloyd-Evans E, Platt F. Lipids on trial: the search for the offending metabolite in Niemann-Pick Type C Disease. Traffic. 2010;11(4):419–428. doi: 10.1111/j.1600-0854.2010.01032.x. - DOI - PubMed

Publication types

LinkOut - more resources